Wei and his colleagues found that the AMPK-mediated phosphorylation of EZH2 at T311 decreases its methyltransferase activity to relieve the EZH2-dependent epigenetic silencing of its target genes and subsequently suppresses ovarian cancer tumorigenesis [55]. This evidence concerns the gene EZH2 and ovarian cancer.